Xellar Biosystems Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 21

Employees

  • Latest Deal Type
  • Series A2

  • Investors
  • 15

Xellar Biosystems General Information

Description

Developer of a biotechnology research tool designed to accelerate drug discovery and development. The company's platform offers artificial intelligence driven modeling, machine learning integration, and wet lab experimental capabilities, enabling pharmaceutical researchers and biotechnology firms to streamline compound identification and improve therapeutic development efficiency.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Shanghai Building 10 Number 6055 Jinhai Highway
  • Fengxian District
  • Shanghai, 100000
  • China
+86 159
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Drug Discovery
Corporate Office
  • Shanghai Building 10 Number 6055 Jinhai Highway
  • Fengxian District
  • Shanghai, 100000
  • China
+86 159

Xellar Biosystems Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Xellar Biosystems Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series A2) 17-Nov-2026 Completed Generating Revenue
5. Early Stage VC (Series A1) 29-Jun-2026 Completed Generating Revenue
4. Early Stage VC (Series A) 01-Apr-2026 Completed Generating Revenue
3. Early Stage VC 27-Apr-2025 Completed Generating Revenue
2. Early Stage VC 16-Jul-2024 $13.8M $23.8M Completed Generating Revenue
1. Seed Round 29-Aug-2022 $10M $10M Completed Startup
To view Xellar Biosystems’s complete valuation and funding history, request access »

Xellar Biosystems Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a biotechnology research tool designed to accelerate drug discovery and development. The company's platform
Discovery Tools (Healthcare)
Shanghai, China
21 As of 2024

San Mateo, CA
 

Boston, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Xellar Biosystems Competitors (39)

One of Xellar Biosystems’s 39 competitors is Genesis Molecular AI, a Venture Capital-Backed company based in San Mateo, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genesis Molecular AI Venture Capital-Backed San Mateo, CA
Asimov Venture Capital-Backed Boston, MA
Exscientia Formerly VC-backed Oxford, United Kingdom
A-Alpha Bio Venture Capital-Backed Seattle, WA
X-37 Venture Capital-Backed South San Francisco, CA
You’re viewing 5 of 39 competitors. Get the full list »

Xellar Biosystems Patents

Xellar Biosystems Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025212883-A1 Systems and methods for controlling perfusion within microfluidic devices Pending 03-Apr-2024
WO-2024072514-A1 Edge effect systems and methods for functionalized microfluidic devices Inactive 30-Sep-2022
WO-2024072512-A1 Methods and systems for functionalizing surfaces for microfluidic devices or other applications Inactive 30-Sep-2022
WO-2024072511-A1 Microfluidic devices containing hydrogels, and techniques for making and using Inactive 30-Sep-2022
WO-2024072513-A1 Pipette interface systems and methods for viscous fluid injection Inactive 30-Sep-2022 G01N1/36
To view Xellar Biosystems’s complete patent history, request access »

Xellar Biosystems Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Xellar Biosystems Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
Shanghai Guofang Private Equity Fund Management Growth/Expansion Minority
Shanghai Guotou Pioneer Private Equity Fund Management Fund of Funds Minority
Cedarlake Capital PE/Buyout Minority
GF Xinde Investment Management PE/Buyout Minority
Oriental Fortune Capital Venture Capital Minority
You’re viewing 5 of 15 investors. Get the full list »

Xellar Biosystems FAQs

  • When was Xellar Biosystems founded?

    Xellar Biosystems was founded in 2021.

  • Where is Xellar Biosystems headquartered?

    Xellar Biosystems is headquartered in Shanghai, China.

  • What is the size of Xellar Biosystems?

    Xellar Biosystems has 21 total employees.

  • What industry is Xellar Biosystems in?

    Xellar Biosystems’s primary industry is Discovery Tools (Healthcare).

  • Is Xellar Biosystems a private or public company?

    Xellar Biosystems is a Private company.

  • What is Xellar Biosystems’s current revenue?

    The current revenue for Xellar Biosystems is .

  • How much funding has Xellar Biosystems raised over time?

    Xellar Biosystems has raised $82.3M.

  • Who are Xellar Biosystems’s investors?

    Shanghai Guofang Private Equity Fund Management, Shanghai Guotou Pioneer Private Equity Fund Management, Cedarlake Capital, GF Xinde Investment Management, and Oriental Fortune Capital are 5 of 15 investors who have invested in Xellar Biosystems.

  • Who are Xellar Biosystems’s competitors?

    Genesis Molecular AI, Asimov, Exscientia, A-Alpha Bio, and X-37 are some of the 39 competitors of Xellar Biosystems.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process